- Players in the regenerative medicine market are
increasing their focus on the launch of highly efficient products
and prevent complications in patients
- Enterprises are growing efforts to spread awareness among
patients on the advantages and risks associated with regenerative
medicines in order to improve clinical outcomes and assist them in
making informed treatment decisions
ALBANY, N.Y., Feb. 17, 2022 /PRNewswire/ -- The global
regenerative medicine market is projected to expand at a CAGR of
10.3% during the forecast period of 2021 to 2028, notes a research
report by Transparency Market Research (TMR).
Regenerative medicine is gaining traction in the healthcare
industry, owing to its ability to provide different cell-tissue
therapeutics and associated products, including natural killer (NK)
cell therapy, stem cell therapy, exosomes, tissue products, and
Chimeric antigen receptor (CAR) T cell therapy.
Request Brochure of Regenerative Medicine Market Research
Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=419
Players operating in the global regenerative medicine market are
spreading awareness among patient pool about different advantages
as well as disadvantages of regenerative medicines. These efforts
are helping enterprises in improving the clinical outcomes. At the
same time, such initiatives are allowing patients to make informed
decisions about their treatments, notes a TMR study on the global
regenerative medicine
market.
The concept of regenerative medicines is comparatively new.
Hence, enterprises operating in the global regenerative medicine
market are increasing their cash in-flow toward advertising and
marketing activities. For instance, several companies are
developing standees that can be placed in hospitals in order to
boost the visibility of their products, thereby increasing
awareness on regenerative medicines. On the back of such efforts,
the global regenerative medicine market is estimated to gain a
valuation of US$ 12.9 Bn by 2028,
highlight analysts at TMR.
Request for Analysis of COVID-19 Impact on Regenerative
Medicine Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=419
Regenerative Medicine Market: Key Findings
- Companies operating in the global regenerative medicine market
are increasing investments in R&D activities that are focused
on the development of highly effective products with the ability to
prevent different complications in patients. These efforts are
helping companies in maintaining their prominent position in the
market for regenerative medicine.
- Generally, older population is at higher risk of internal and
external injuries, including joint and bone injuries. Hence,
companies operating in the global regenerative medicine market are
expected to gain sizable business prospects with increase in the
older population globally.
Make an Enquiry before Buying -
https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=419
Regenerative Medicine Market: Growth Boosters
- Increase in cases of genetic disorders, cancer, and chronic
diseases across the globe is resulting in promising business
prospects in the regenerative medicine market
- Technological advancements in the stem cell-based therapy are
projected to help in the expansion of the global regenerative
medicine market in the years ahead
Regenerative Medicine Market: Regional Analysis
- The North America regenerative
medicine market is estimated to maintain its dominant position
during the forecast period, owing to rise in R&D activities
performed in the U.S. Moreover, the regional market is being driven
by a surge in investments by governments as well as private players
operating in North America. In
addition, increase in the number of older population, which is more
prone to different joint and bone issues, is leading to
revenue-generating opportunities in the North America regenerative medicine
market.
- The regenerative medicine market is prognosticated to gain
lucrative prospects in Asia
Pacific, owing to the presence of sizable patient pool,
improving healthcare infrastructure, and increasing understanding
on regenerative medicines. Furthermore, the Asia Pacific market is anticipated to observe
significant sales growth due to improved spending on healthcare by
regional population, according to TMR study.
Request a Sample of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=419
Regenerative Medicine Market: Key Players
Some of the key players profiled in the report are:
- Anika Therapeutics, Inc.
- Smith & Nephew plc
- Baxter International, Inc.
- DePuy Synthes, Inc.
- Medtronic, Inc.
- Stryker Corporation
- Zimmer Holdings, Inc.
- CONMED Corporation
- Arthrex, Inc.
Regenerative Medicine Market Segmentation
Technology
- Biomaterials
- Stem Cells
- Tissue Engineering
Application
- Bone Graft Substitutes
- Osteoarticular Diseases
- Allogeneic Bones
- Autogenic Bones
- Others
Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East &
Africa
Modernization of healthcare in terms of both infrastructure
and services have pushed the healthcare industry to new heights,
Stay Updated with Latest Healthcare Industry Research
Reports by Transparency Market Research:
Asthma Spacers Market: The global asthma spacers market was
valued at US$ 1,330.56 Mn in 2017 and
is projected to expand at a CAGR of 3.7% during forecast period
from 2018 to 2026. The global asthma spacers market is anticipated
to be driven by technological advancements and increase in use of
spacers with metered dose inhalers for the management of
asthma.
Medical Imaging Phantoms Market: The global medical imaging
phantoms market was valued at US$ 131.2
Mn in 2017 and is projected to expand at a CAGR of 3.6% from
2018 to 2026. Improved medical imaging using medical phantoms,
reduced exposure to radiation and increase in efficiency of medical
devices, and rise in adoption of advanced imaging methods are
anticipated to propel the global market from 2018 to 2026.
Gene Therapy Market: New product approvals, promising
therapeutic outcomes of gene therapy, and high prevalence of
non-Hodgkin Lymphoma are anticipated to drive the global market in
the next few years. Europe is
projected to dominate the global gene therapy market, followed by
U.S., by the end of 2026.
About Us
Transparency Market Research is a global market intelligence
company, providing global business information reports and
services. Our exclusive blend of quantitative forecasting and
trends analysis provides forward-looking insight for thousands of
decision makers. Our experienced team of Analysts, Researchers, and
Consultants, use proprietary data sources and various tools and
techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a
team of research experts, so that it always reflects the latest
trends and information. With a broad research and analysis
capability, Transparency Market Research employs rigorous primary
and secondary research techniques in developing distinctive data
sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our
YouTube Channel and hit subscribe for Future Update
- https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Mr. Rohit
Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY – 12207
United States
USA - Canada Toll Free:
866-552-3453
Email: sales@transparencymarketresearch.com
Follow Us: Twitter | LinkedIn
Blog: https://tmrblog.com
Browse PR -
https://www.transparencymarketresearch.com/pressrelease/regenerative-medicines-market.htm
Logo:
https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg